comparemela.com

Latest Breaking News On - First mercantile trust co - Page 10 : comparemela.com

Q2 2022 Earnings Estimate for APA Co Issued By Capital One Financial (NASDAQ:APA)

APA Co. (NASDAQ:APA – Get Rating) – Equities researchers at Capital One Financial upped their Q2 2022 EPS estimates for APA in a research note issued to investors on Wednesday, May 18th. Capital One Financial analyst B. Velie now forecasts that the company will earn $3.22 per share for the quarter, up from their prior […]

Jefferies Financial Group Weighs in on Monro, Inc s Q1 2024 Earnings (NASDAQ:MNRO)

Monro, Inc. (NASDAQ:MNRO – Get Rating) – Investment analysts at Jefferies Financial Group issued their Q1 2024 earnings estimates for Monro in a report issued on Thursday, May 19th. Jefferies Financial Group analyst B. Jordan expects that the auto parts company will earn $0.43 per share for the quarter. Jefferies Financial Group also issued estimates […]

Caesarstone (NASDAQ:CSTE) Downgraded to Sell at Zacks Investment Research

Caesarstone (NASDAQ:CSTE – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Monday, Zacks.com reports. According to Zacks, “CaesarStone Ltd manufactures engineered quartz surfaces for residential and commercial buildings as countertops, vanities, wall cladding, floors and other interior surfaces. The company’s product […]

$0 55 Earnings Per Share Expected for Monro, Inc (NASDAQ:MNRO) This Quarter

Equities research analysts expect Monro, Inc. (NASDAQ:MNRO – Get Rating) to announce earnings per share of $0.55 for the current quarter, according to Zacks. Two analysts have made estimates for Monro’s earnings. Monro also reported earnings per share of $0.55 during the same quarter last year. The firm is expected to announce its next quarterly […]

-$2 29 EPS Expected for Reata Pharmaceuticals, Inc (NASDAQ:RETA) This Quarter

Analysts expect Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Rating) to announce earnings per share of ($2.29) for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Reata Pharmaceuticals’ earnings. Reata Pharmaceuticals posted earnings per share of ($2.00) in the same quarter last year, which would suggest a negative year-over-year growth rate of […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.